|
Year to Mar 2025
12 months to Mar 31, 2025
|
Year to Mar 2024
12 months to Mar 31, 2024
|
Year to Mar 2023
12 months to Mar 31, 2023
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Loss for the year | |||
| Items not affecting cash | |||
| Depreciation and amortisation | |||
| Impairment of exploration and evaluation assets | |||
| Loan receivable accrued interest | |||
| Loss on disposal of equipment | |||
| Premium on flow-through shares | |||
| Shares issued for license agreement | |||
| Share-based compensation | |||
| Valuation allowance on accounts receivable | |||
| Valuation allowance on inventory | |||
| Net change in non-cash working capital balances | |||
| Cash flows used in operating activities | |||
| INVESTING ACTIVITIES | |||
| Loan receivable advanced | |||
| Loan receivable repayment | |||
| Mineral exploration and evaluation expenditures capitalised | |||
| Proceeds on sale of property and equipment | |||
| Purchase of property and equipment | |||
| Cash flows from (used in) investing activities | |||
| FINANCING ACTIVITIES | |||
| Payments on lease liability | |||
| Payments on long-term debt | |||
| Proceeds from stock options exercised | |||
| Proceeds from warrants exercised | |||
| Share issue costs | |||
| Shares purchased for cancellation | |||
| Units issued | |||
| Unit issue costs | |||
| Warrant issue costs | |||
| Cash flows used in financing activities | |||
| Change in cash and cash equivalents during the year | |||
| Cash and cash equivalents, beginning of year | |||
| Cash and cash equivalents, end of year |
Loading...
